The Greek pharmaceutical sector is struggling with underfunding, as companies cover nearly 83% of hospital drug costs.

The new key figures from the NZa show that Dutch expenditure on expensive medicines remains stable,” says Mark Kramer, ...

Last week’s significant news included Denmark-based CNS drugmaker Lundbeck reaching agreement to acquire US firm Longboard ...

The US Food and Drug Administration has approved Vyloy (zolbetuximab-clzb), a claudin 18.2 (CLDN18.2)-directed cytolytic ...

A century later, that sentiment is as pertinent as ever. Artificial Intelligence (AI) is being incorporated into a myriad of ...

Shanghai-based biopharma LaNova Medicines has raised 3 billion yuan ($41 million) in a series C round led by China ...

OmniaBio, a subsidiary of Canada's Centre for Commercialization of Regenerative Medicine, has opened a 120,000-square-foot ...

Taiwan-based REGiMMUNE, a biopharma creating immunotherapies through the power of regulatory T cells (Tregs), and ...

As the European Parliament prepares for the confirmation hearings of the new Commissioners, the Open Trade Coalition is ...

US biotech company Sage Therapeutics is to slash a third of its remaining jobs - just a year after cutting 40% of its prior workforce.

After a couple of negative decisions, the US Food and Drug Administration (FDA) has approved Vyalev (foscarbidopa and ...

Texas, USA-based Lexicon Pharmaceuticals announced that Viatris has obtained an exclusive license from Lexicon to ...